ASAM Pocket Guidelines and Patient Guide

Benzodiazepine Tapering

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1532950

Contents of this Issue

Navigation

Page 6 of 29

7 Table 1. Potential Benefits and Risks of Continued BZD Use and BZD Tapering a Potential benefits Potential risks BZD use BZD use BZD taper • Effectiveness in managing a patient's mental and physical health condition(s) • Related functional improvements • Quality of life improvements b • Oversedation, including consideration of use with other sedating medications, alcohol, or other drugs • Falls and related injuries • Memory and cognitive impacts • Motor vehicle accidents • Medical safety concerns (e.g., medication interactions) • Impacts on co-occurring mental and physical health conditions • Disrupted sleep patterns • Impacts on work and family responsibilities • Diversion • Substance use disorder • Overdose • Fetal harm • Suicidality • Withdrawal symptoms, including severe or complicated withdrawal (e.g., seizures, delirium) • Recurrence of the condition for which BZD were prescribed • Impacts on co-occurring mental and physical health conditions • Protracted withdrawal • Return to illicit BZD use • Transition to illicit BZD use c a Clinicians should consider the likelihood of each benefit and risk for the individual patient. e narrative notes risk/hazard ratios available in the published literature. b Including compassionate use for end of life or palliative care. c Including risks associated with counterfeit BZDs from the illicit drug market, such as contamination with highly potent synthetic opioids (HPSOs) (e.g., fentanyl) and novel synthetic substances.

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Benzodiazepine Tapering